A clinical study of MK-1403 in healthy men (MK-1403-004)
This study, called MK-1403-004, is checking a new medicine named MK-1403. It's a very early stage study, meaning it's the first time this medicine is being given to people. Researchers want to learn how the medicine behaves in healthy men – things like how much of it gets into the body, how quickly it's used up, and if it causes any side effects. This information is important because eventually, this medicine might be used to treat conditions like atherosclerosis, which is a build-up of fats and other substances in and on your artery walls, making them narrow. By understanding it better now, doctors can decide if it's safe and worth studying further for patients.
At a glance
What is this study about?
This research study is focused on a new medicine called MK-1403. We know from research that medicines sometimes need to go through several stages of testing before they can be used widely. This particular study is an early stage, which means it's one of the first times this new medicine is being given to people. The main goal at this stage isn't to treat a specific illness, but rather to understand how the medicine works in the human body. Think of it like learning how a brand new car engine runs – how much fuel it uses, how hot it gets, and if it runs smoothly.
The medicine is being studied because it could potentially help with conditions like atherosclerosis. Atherosclerosis is a common and serious condition where your arteries, which are the blood vessels that carry oxygen and nutrients from your heart to the rest of your body, become hardened and narrowed. This happens due to a build-up of fatty materials inside them. This can lead to serious health problems like heart attacks and strokes. By studying MK-1403, scientists hope to find out if it has properties that could make it a useful treatment in the future.
Since this is an early stage study, it focuses on healthy volunteers. This helps researchers understand the basic effects of the medicine without other health conditions making the results unclear. The information collected from this study is crucial for deciding if it's safe and promising enough to continue to bigger studies with patients who actually have atherosclerosis. It's an important step in developing new medicines that could improve people's health.
Key takeaways
- This is an early-stage study (Phase I) of a new medicine called MK-1403.
- It aims to understand how the medicine works in healthy men.
- The findings could help in developing future treatments for atherosclerosis.
- Only men aged 18 and over, who are generally healthy, can take part.
- You would be closely monitored for any side effects.
- You can stop participating at any time.
Who may be eligible?
This study is specifically looking for male volunteers who are at least 18 years old. There isn't an upper age limit mentioned, but you would still need to meet all other health requirements.
To be considered for this study, you would also need to be a generally healthy individual. This means you shouldn't have any major ongoing health problems or be taking certain medications that could interfere with the study medicine or affect the results.
The research team will carry out several checks and tests to make sure you are healthy enough to take part and that the study is safe for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you male?
- Are you 18 years old or older?
- Do you consider yourself generally healthy?
- Are you willing to attend regular clinic visits and assessments?
What does participation involve?
If you decide to take part, you would receive the study medicine, MK-1403. As this is an early study, it's primarily about understanding how your body handles the medicine. This usually involves regular visits to the clinic, where you might have blood samples taken, your vital signs (like blood pressure and heart rate) checked, and other assessments to see how you are feeling and how the medicine is affecting you. You might stay at the clinic for certain periods. The total duration of your participation, including the number of visits and follow-up, would be fully explained by the study team before you agree to take part.
Potential risks and benefits
Locations (1)
- —UnverifiedBelgium
Common questions
What is atherosclerosis?
Atherosclerosis is when fatty stuff builds up inside your arteries, making them narrower and harder, which can lead to heart problems or strokes.
Why is this study only for healthy men?
Early studies often start with healthy volunteers to see how the medicine works in the body without other health conditions making the results complicated.
Will I be given the actual medicine for atherosclerosis?
This study is an early test of a new medicine, MK-1403. It's not yet known if it will become a treatment for atherosclerosis, but this study helps find out.
What does a 'Phase I' study mean?
Phase I means it's one of the first times the new medicine is given to people. The main goals are to check its safety and how the body handles it.
Will I get paid for taking part?
Payment for participation or compensation for travel is common in research studies. The study team will give you full details about this.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.